Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,672 | 491 | 99.8% |
| Education | $22.66 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,317 | 57 | $0 (2024) |
| COLOPLAST CORP | $1,274 | 36 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $1,125 | 50 | $0 (2024) |
| Astellas Pharma US Inc | $711.76 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $612.11 | 44 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $569.77 | 26 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $500.68 | 23 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $465.32 | 25 | $0 (2024) |
| Blue Earth Diagnostics Limited | $361.07 | 17 | $0 (2024) |
| Boston Scientific Corporation | $345.46 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,130 | 90 | ABBVIE INC. ($437.59) |
| 2023 | $2,457 | 101 | AbbVie Inc. ($539.94) |
| 2022 | $1,838 | 74 | Boston Scientific Corporation ($265.73) |
| 2021 | $1,135 | 69 | Janssen Biotech, Inc. ($260.09) |
| 2020 | $418.90 | 22 | Janssen Biotech, Inc. ($89.91) |
| 2019 | $1,418 | 69 | Endo Pharmaceuticals Inc. ($248.56) |
| 2018 | $739.28 | 43 | Dendreon Pharmaceuticals LLC ($154.53) |
| 2017 | $558.72 | 25 | Coloplast Corp ($181.36) |
All Payment Transactions
493 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Oncology | ||||||
| 12/10/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: HORMONE THERAPY | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: UROLOGY | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Oncology | ||||||
| 11/06/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Endo USA, Inc. | XIAFLEX (Biological), AVEED | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Oncology | ||||||
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: UROLOGY | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diagnostic Imaging | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: HORMONE THERAPY | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Oncology | ||||||
| 09/16/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,390 | 3,010 | $570,633 | $145,992 |
| 2022 | 24 | 2,217 | 2,895 | $705,922 | $152,767 |
| 2021 | 29 | 2,635 | 10,310 | $637,549 | $178,911 |
| 2020 | 28 | 2,610 | 4,496 | $566,768 | $151,527 |
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 576 | 829 | $198,960 | $73,979 | 37.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 54 | 69 | $31,050 | $12,070 | 38.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $37,230 | $11,734 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 133 | $22,555 | $8,775 | 38.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 273 | 339 | $19,662 | $6,019 | 30.6% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 12 | 12 | $22,572 | $5,324 | 23.6% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 78 | 92 | $23,460 | $5,309 | 22.6% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 42 | 42 | $16,800 | $3,999 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 318 | 404 | $4,848 | $3,386 | 69.8% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 102 | 128 | $10,240 | $2,906 | 28.4% |
| 55874 | Injection of biodegradable material next to prostate | Facility | 2023 | 16 | 16 | $119,824 | $1,804 | 1.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 27 | 35 | $7,525 | $1,671 | 22.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 186 | 200 | $23,040 | $1,584 | 6.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 58 | 58 | $4,060 | $1,438 | 35.4% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 38 | 56 | $4,144 | $1,391 | 33.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,080 | $1,244 | 30.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 168 | 220 | $3,300 | $859.25 | 26.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 23 | $3,105 | $621.46 | 20.0% |
| 55876 | Placement of device in prostate for radiation therapy | Facility | 2023 | 16 | 16 | $8,800 | $559.86 | 6.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 38 | $2,090 | $416.25 | 19.9% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 11 | 16 | $960.00 | $309.50 | 32.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 59 | 63 | $504.00 | $208.01 | 41.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 11 | $550.00 | $193.21 | 35.1% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 62 | 91 | $1,274 | $189.83 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 511 | 715 | $171,600 | $64,455 | 37.6% |
About Dr. Jason Szobota, MD
Dr. Jason Szobota, MD is a Urology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1275709982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Szobota, MD has received a total of $10,695 in payments from pharmaceutical and medical device companies, with $2,130 received in 2024. These payments were reported across 493 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($10,672).
As a Medicare-enrolled provider, Szobota has provided services to 9,852 Medicare beneficiaries, totaling 20,711 services with total Medicare billing of $629,196. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Richmond, VA
- Active Since 05/02/2008
- Last Updated 10/28/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1275709982
Products in Payments
- PROVENGE (Drug) $1,191
- BOTOX (Biological) $847.04
- Titan (Device) $743.74
- XIAFLEX (Biological) $587.35
- ERLEADA (Drug) $465.42
- XTANDI (Drug) $445.58
- LUPRON DEPOT (Drug) $399.15
- ORGOVYX (Drug) $383.90
- TITAN (Device) $336.98
- Nubeqa (Drug) $306.69
- GEMTESA (Drug) $305.73
- Xtandi (Drug) $292.77
- Axumin (Drug) $267.45
- JELMYTO (Drug) $256.01
- CAMCEVI (Drug) $233.53
- LYNPARZA (Drug) $187.54
- Xofigo (Drug) $158.63
- Erleada (Drug) $155.23
- PLUVICTO (Drug) $153.20
- UroLift (Device) $145.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Richmond
Dr. Anthony Sliwinski, M.d, M.D
Urology — Payments: $76,833
Dr. Lonny Green, M.d, M.D
Urology — Payments: $65,404
Dr. John Delisio, M.d, M.D
Urology — Payments: $38,212
Dr. Eugene Kramolowsky, M.d, M.D
Urology — Payments: $30,695
Dr. Charles Seabury, M.d, M.D
Urology — Payments: $27,026
Dr. Michael Franks, Md, MD
Urology — Payments: $24,609